4//SEC Filing
Dorsch Marion 4
Accession 0001179110-20-004115
CIK 0001597264other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 4:22 PM ET
Size
8.4 KB
Accession
0001179110-20-004115
Insider Transaction Report
Form 4
Dorsch Marion
Chief Scientific Officer
Transactions
- Sale
Common Stock
2020-03-23$53.43/sh−241$12,877→ 16,024 total - Sale
Common Stock
2020-03-23$51.52/sh−774$39,876→ 15,250 total - Sale
Common Stock
2020-03-23$55.14/sh−199$10,973→ 16,265 total
Footnotes (4)
- [F1]Effected pursuant to a trading plan adopted on April 3, 2019 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.27 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) to this Form 4.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.41 to $53.58 per share.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.01 to $51.93 per share.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001690460
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 4:22 PM ET
- Size
- 8.4 KB